Clinical Trial Update: Application of Nanopore Adaptive Sequencing

View source ↗

Summary

Clinical trial update on applying nanopore adaptive sequencing, sponsored by Shenzhen Third People's Hospital, investigating liver transplant infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplant Infection

Snippet

Sponsor: Shenzhen Third People's Hospital | Conditions: Liver Transplant Infection | Status: NOT_YET_RECRUITING